Health system strengthening: Integration of breast cancer care for improved outcomes.
breast cancer
diagnostic
essential medicines list
national cancer control plans
national health insurance
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
15 05 2020
15 05 2020
Historique:
received:
28
01
2020
revised:
21
02
2020
accepted:
29
02
2020
entrez:
30
4
2020
pubmed:
30
4
2020
medline:
22
5
2021
Statut:
ppublish
Résumé
The adoption of the goal of universal health coverage and the growing burden of cancer in low- and middle-income countries makes it important to consider how to provide cancer care. Specific interventions can strengthen health systems while providing cancer care within a resource-stratified perspective (similar to the World Health Organization-tiered approach). Four specific topics are discussed: essential medicines/essential diagnostics lists; national cancer plans; provision of affordable essential public services (either at no cost to users or through national health insurance); and finally, how a nascent breast cancer program can build on existing programs. A case study of Zambia (a country with a core level of resources for cancer care, using the Breast Health Global Initiative typology) shows how a breast cancer program was built on a cervical cancer program, which in turn had evolved from the HIV/AIDS program. A case study of Brazil (which has enhanced resources for cancer care) describes how access to breast cancer care evolved as universal health coverage expanded. A case study of Uruguay shows how breast cancer outcomes improved as the country shifted from a largely private system to a single-payer national health insurance system in the transition to becoming a country with maximal resources for cancer care. The final case study describes an exciting initiative, the City Cancer Challenge, and how that may lead to improved cancer services.
Identifiants
pubmed: 32348567
doi: 10.1002/cncr.32871
pmc: PMC7197416
mid: NIHMS1578361
doi:
Types de publication
Comparative Study
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2353-2364Subventions
Organisme : Susan G. Komen
ID : SAC170082
Pays : United States
Organisme : National Comprehensive Cancer Network
Organisme : Novartis
Organisme : NCI NIH HHS
ID : 1R13CA224776-01A1
Pays : United States
Organisme : American Society of Clinical Oncology
Organisme : pH Trust
Organisme : Journal of Global Oncology
Organisme : Pfizer
Organisme : Union for International Cancer Control
Organisme : American Society of Clinical Pathology
Organisme : NCI NIH HHS
ID : R13 CA224776
Pays : United States
Organisme : Seattle Cancer Care Alliance
Organisme : Cepheid
Organisme : University of Washington
Organisme : GE Healthcare
Organisme : UE LifeSciences
Organisme : Fred Hutchinson Cancer Research Center
Organisme : National Breast Cancer Foundation
Organisme : Susan G. Komen
ID : GSP18BHGI001
Pays : United States
Informations de copyright
© 2020 American Cancer Society.
Références
J Glob Oncol. 2019 Aug;5:1-3
pubmed: 31393753
BMC Cancer. 2015 Aug 18;15:591
pubmed: 26283654
Lancet Oncol. 2015 Sep;16(11):1193-224
pubmed: 26427363
Breast Care (Basel). 2008;3(1):29-32
pubmed: 20824017
Ann Oncol. 2017 Nov 1;28(11):2633-2647
pubmed: 28950323
J Clin Oncol. 2018 Apr 10;36(11):1121-1127
pubmed: 29489428
Med J Malaysia. 2014 Aug;69 Suppl A:8-22
pubmed: 25417947
Cancer. 2008 Oct 15;113(8 Suppl):2282-96
pubmed: 18837020
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Ann Oncol. 2018 Aug 1;29(8):1634-1657
pubmed: 30032243
Breast. 2011 Apr;20 Suppl 2:S20-9
pubmed: 21376593
Breast J. 2003 May-Jun;9 Suppl 2:S40-1
pubmed: 12713495
Semin Radiat Oncol. 2017 Apr;27(2):169-175
pubmed: 28325244
Cad Saude Publica. 2018 Jun 21;34(6):e00074817
pubmed: 29947654
Lancet Oncol. 2018 Oct;19(10):e546-e555
pubmed: 30268693
PLoS Med. 2010 Jan;7(1):e1000089
pubmed: 20069038
Lancet Public Health. 2019 Oct;4(10):e492
pubmed: 31451443
J Glob Oncol. 2018 Sep;4:1-8
pubmed: 30241176
Cancer. 2008 Oct 15;113(8 Suppl):2221-43
pubmed: 18816619
BMC Cancer. 2014 Mar 20;14:212
pubmed: 24650245
Int J Gynaecol Obstet. 2019 Mar;144(3):297-301
pubmed: 30580443
J Glob Oncol. 2019 Jul;5:1-9
pubmed: 31260395